Published in J Virol on February 01, 1995
Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci U S A (2005) 2.86
Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J Virol (2004) 2.44
Evidence of infection with simian type D retrovirus in persons occupationally exposed to nonhuman primates. J Virol (2001) 1.42
In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy. J Virol (2000) 1.18
Characterization and comparison of recombinant simian immunodeficiency virus from drill (Mandrillus leucophaeus) and mandrill (Mandrillus sphinx) isolates. J Virol (2003) 1.13
Ancient origin and molecular features of the novel human T-lymphotropic virus type 3 revealed by complete genome analysis. J Virol (2006) 1.10
Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function. J Virol (2000) 1.04
Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type 2. J Virol (1996) 1.03
Novel simian foamy virus infections from multiple monkey species in women from the Democratic Republic of Congo. Retrovirology (2012) 1.03
Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins. J Clin Microbiol (1995) 1.00
African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies. J Virol (1998) 0.97
Emergence of a novel and highly divergent HTLV-3 in a primate hunter in Cameroon. Virology (2010) 0.97
Identification and molecular characterization of new simian T cell lymphotropic viruses in nonhuman primates bushmeat from the Democratic Republic of Congo. AIDS Res Hum Retroviruses (2011) 0.91
Genetic characterization of the complete genome of a highly divergent simian T-lymphotropic virus (STLV) type 3 from a wild Cercopithecus mona monkey. Retrovirology (2009) 0.85
The simian T-lymphotropic/leukemia virus from Pan paniscus belongs to the type 2 family and infects Asian macaques. J Virol (1997) 0.85
Molecular phylogeny of human T-cell leukemia virus type I and II of Amerindians in Colombia and Chile. J Mol Evol (1997) 0.83
Origin and prevalence of human T-lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) among indigenous populations in the Americas. Rev Inst Med Trop Sao Paulo (2015) 0.80
Molecular subtyping of human T-cell lymphotropic virus type 2 by single-strand conformation polymorphism analysis. Retrovirus Epidemiology Donor Study Group. J Clin Microbiol (1995) 0.79
Dual Simian Foamy Virus/Human Immunodeficiency Virus Type 1 Infections in Persons from Côte d'Ivoire. PLoS One (2016) 0.78
The Sonoda-Tajima Cell Collection: a human genetics research resource with emphasis on South American indigenous populations. Genome Biol Evol (2011) 0.78
Molecular evidence for infection by HTLV-2 among individuals with negative serological screening tests for HTLV antibodies. Epidemiol Infect (2006) 0.77
A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res (1984) 181.98
The ribosomal database project. Nucleic Acids Res (1993) 17.20
Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet (1985) 13.47
Ribosomal RNA: a key to phylogeny. FASEB J (1993) 7.26
A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science (1982) 5.30
Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A (1984) 4.97
Native American mitochondrial DNA analysis indicates that the Amerind and the Nadene populations were founded by two independent migrations. Genetics (1992) 4.78
Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. Proc Natl Acad Sci U S A (1985) 4.28
Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. J Virol (1992) 1.94
HTLV-1 and polymyositis in Jamaica. Lancet (1989) 1.51
In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies. J Virol (1991) 1.46
A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med (1986) 1.44
Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci U S A (1990) 1.36
The epidemiology of the human T-cell lymphotrophic virus type I and type II: etiologic role in human disease. Transfusion (1991) 1.29
Endemic human T cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis (1992) 1.22
Genetic heterogeneity in human T-cell leukemia/lymphoma virus type II. J Virol (1993) 1.19
Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS. Lancet (1984) 1.19
Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals. J Clin Microbiol (1992) 1.19
Comparative analysis of nucleotide sequences of the partial envelope gene (5' domain) among human T lymphotropic virus type I (HTLV-I) isolates. Virology (1991) 1.16
Evolutionary insights on the origin of human T-cell lymphoma/leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea. J Virol (1992) 1.10
Multiple isolates and characteristics of human T-cell leukemia virus type II. J Virol (1992) 1.07
Complete nucleotide sequence of an Amerindian human T-cell lymphotropic virus type II (HTLV-II) isolate: identification of a variant HTLV-II subtype b from a Guaymi Indian. J Virol (1993) 1.07
HTLV-II seroprevalence in pygmies across Africa since 1970. AIDS Res Hum Retroviruses (1993) 1.06
Primate T-lymphotropic virus type I LTR sequence variation and its phylogenetic analysis: compatibility with an African origin of PTLV-I. Virology (1994) 1.06
Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. Blood (1992) 1.01
Low human T cell leukemia virus type II seroprevalence in Africa. J Infect Dis (1994) 1.00
Endemic human T cell leukemia virus type II infection in southwestern US Indians involves two prototype variants of virus. J Infect Dis (1993) 0.97
HTLV-II infection in Florida Indians. AIDS Res Hum Retroviruses (1993) 0.95
Large granular lymphocytosis in a patient infected with HTLV-II. AIDS Res Hum Retroviruses (1993) 0.93
HTLV-II infection in Italian drug abusers. Lancet (1990) 0.92
High rate of infection with the human T-cell leukemia retrovirus type II in four Indian populations of Argentina. Virology (1993) 0.92
Geographical subtypes demonstrated by RFLP following PCR in the LTR region of HTLV-I. AIDS Res Hum Retroviruses (1992) 0.92
Complete nucleotide sequence of HTLV-II isolate NRA: comparison of envelope sequence variation of HTLV-II isolates from U.S. blood donors and U.S. and Italian i.v. drug users. Virology (1993) 0.91
Isolation and characterization of simian T-cell leukemia virus type II from New World monkeys. J Virol (1994) 0.91
Endemic HTLV-II infection among Tobas and Matacos Amerindians from north Argentina. J Acquir Immune Defic Syndr (1993) 0.88
Nucleotide sequence analysis of human T cell leukemia virus, type II (HTLV-II) isolates. AIDS Res Hum Retroviruses (1993) 0.88
Dominance of HTLV type I-specific antibody responsiveness in Old World monkeys. AIDS Res Hum Retroviruses (1991) 0.87
Coexistence of human T-lymphotropic virus types I and II among the Wayuu Indians from the Guajira Region of Colombia. AIDS Res Hum Retroviruses (1992) 0.87
Association of '(tropical) ataxic neuropathy' with HTLV-II. Virus Res (1993) 0.86
Evidence for mother-to-child transmission of human T lymphotropic virus type II. J Infect Dis (1993) 0.85
Molecular characterization of two isolates of human T cell leukaemia virus type II from Italian drug abusers and comparison of genome structure with other isolates. J Gen Virol (1993) 0.84
Identification of human T cell leukemia virus type IIb infection in the Wayu, an aboriginal population of Colombia. Jpn J Cancer Res (1993) 0.83
A distinct molecular variant of HTLV-IIB in Gabon, Central Africa. AIDS Res Hum Retroviruses (1994) 0.82
HTLV-I/II infections in Spain. The HTLV-I/II Spanish Study Group. Int J Epidemiol (1993) 0.82
Isolation and genomic analysis of human T lymphotropic virus type II from Ghana. AIDS Res Hum Retroviruses (1993) 0.82
A new endemic focus of human T lymphotropic virus type II carriers among Orinoco natives in Colombia. J Infect Dis (1993) 0.79
Simian immunodeficiency virus in people. N Engl J Med (1994) 0.78
Detection of human T lymphotropic virus type II/b in human immunodeficiency virus type 1-coinfected persons in southeastern Italy. J Infect Dis (1993) 0.78
HTLV-II infection is rare in patients with large granular lymphocyte leukemia. J Acquir Immune Defic Syndr (1994) 0.78
Prevalence of HTLV-II in HIV-1-infected drug addicts in Marseille. Eur J Epidemiol (1993) 0.77
Diagnosis of infection with human T-lymphotropic virus type II (HTLV-II) in Norwegian HIV-infected individuals. Clin Diagn Virol (1993) 0.76
Chronic fatigue syndrome: a working case definition. Ann Intern Med (1988) 9.12
The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit. Ann Intern Med (1982) 6.62
HIV-1 nomenclature proposal. Science (2000) 6.61
Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med (1982) 4.54
Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science (1999) 4.44
Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS (1999) 4.39
The frequency of a Norwalk-like pattern of illness in outbreaks of acute gastroenteritis. Am J Public Health (1982) 3.78
Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med (1994) 3.73
Acquired immunodeficiency syndrome (AIDS) associated with transfusions. N Engl J Med (1984) 3.22
Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J Viral Hepat (2009) 3.02
High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans. Science (1989) 3.00
The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr (1990) 2.65
Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis (1996) 2.64
European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis (2011) 2.47
HIV risk factors in three geographic strata of rural Rakai District, Uganda. AIDS (1992) 2.41
Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells. J Virol (2000) 2.37
Brief report: infection of a laboratory worker with simian immunodeficiency virus. N Engl J Med (1994) 2.32
Detection of Norwalk virus antibodies and antigen with a biotin-avidin immunoassay. J Clin Microbiol (1985) 2.28
Transfusion transmission of human T-lymphotropic virus types I and II: serologic and polymerase chain reaction results in recipients identified through look-back investigations. Transfusion (1993) 2.03
Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons. Proc Natl Acad Sci U S A (2001) 2.02
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat (2011) 2.00
[Treatment and prophylaxis of the principal infections associated with the human immunodeficiency virus]. Med Clin (Barc) (1993) 1.96
Physiologic role of cold-insoluble globulin in systemic host defense: implications of its characterization as the opsonic alpha 2-surface-binding glycoprotein. Ann N Y Acad Sci (1978) 1.86
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Med (2008) 1.84
Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol (2001) 1.83
Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review. Clin Infect Dis (1994) 1.82
Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. MMWR CDC Surveill Summ (1999) 1.81
A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? JAMA (1987) 1.75
Multiple groups of novel retroviral genomes in pigs and related species. J Virol (2001) 1.67
Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines. Bone Marrow Transplant (2001) 1.66
An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition. J Infect Dis (1984) 1.64
A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease. Ropinirole Study Group. Neurology (1998) 1.60
Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Mol Psychiatry (2012) 1.59
Introduction of HIV drug-resistance testing in clinical practice. AIDS (1999) 1.58
Drug resistance in patients experiencing early virological failure under a triple combination including indinavir. AIDS (2001) 1.56
Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med (1992) 1.56
Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients. Am J Transplant (2011) 1.54
Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry. J Virol (1998) 1.53
Detection of diverse variants of human immunodeficiency virus-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees by using generic pol and env primer pairs. J Infect Dis (2000) 1.52
Reference sample method for cardiac output and regional blood flow determinations in the rat. J Appl Physiol (1976) 1.52
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis (1996) 1.51
Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers. J Clin Microbiol (1999) 1.51
Gastroenteritis due to Norwalk virus: an outbreak associated with a municipal water system. J Infect Dis (1982) 1.49
Simian foamy virus infection among zoo keepers. Lancet (2000) 1.48
Component-resolved diagnosis of vespid venom-allergic individuals: phospholipases and antigen 5s are necessary to identify Vespula or Polistes sensitization. Allergy (2012) 1.48
Predominance of HIV type 1 subtype G among commercial sex workers from Kinshasa, Democratic Republic of Congo. AIDS Res Hum Retroviruses (2001) 1.48
Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study. Br J Haematol (1997) 1.47
An outbreak of acute nonbacterial gastroenteritis in a nursing home. Demonstration of person-to-person transmission by temporal clustering of cases. Am J Epidemiol (1982) 1.46
Hantavirus pulmonary syndrome associated with entering or cleaning rarely used, rodent-infested structures. J Infect Dis (1995) 1.45
Epidemiology of Epidemic Dropsy. Br Med J (1937) 1.45
Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma. J Virol Methods (2005) 1.45
Concurrent infections and HIV pathogenesis. AIDS (2000) 1.44
[Strongyloidiasis and HTLV-I infection]. Med Clin (Barc) (1999) 1.44
Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin Infect Dis (2001) 1.44
A molecular epidemiologic survey of HIV in Uganda. HIV Variant Working Group. AIDS (1998) 1.43
Unexplained deaths due to possibly infectious causes in the United States: defining the problem and designing surveillance and laboratory approaches. The Unexplained Deaths Working Group. Emerg Infect Dis (1996) 1.43
Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-alpha. J Infect Dis (1998) 1.42
Evidence of infection with simian type D retrovirus in persons occupationally exposed to nonhuman primates. J Virol (2001) 1.42
Hepatitis C is a poor prognostic indicator in black kidney transplant recipients. Transplantation (1993) 1.42
Effect of high altitude on neutrophil counts in newborn infants. J Pediatr (1991) 1.41
[Interferon in chronic hepatitis in patients infected by the human immunodeficiency virus: yes or no?]. Med Clin (Barc) (1992) 1.40
Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 1.40
Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance. EMBO J (2000) 1.40
[An esophageal ulcer due to cytomegalovirus in a female patient infected with the human immunodeficiency virus without serious immunosuppression: is this an acquired immunodeficiency syndrome?]. Med Clin (Barc) (1992) 1.40
Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays. J Clin Microbiol (1990) 1.40
[Antiretroviral treatment against HIV]. Med Clin (Barc) (1995) 1.39
[Intensification of antiretroviral treatment]. Rev Clin Esp (2000) 1.39
HTLV-I and HTLV-II infections in Spain. Vox Sang (1993) 1.39
[Complications in Mediterranean boutonneuse fever: prospective study of 78 patients]. Rev Clin Esp (1989) 1.39
Hantavirus pulmonary syndrome in Florida: association with the newly identified Black Creek Canal virus. Am J Med (1996) 1.38
[Study of 164 episodes of infectious endocarditis in drug addicts: comparison of HIV positive and negative patients]. Rev Clin Esp (1994) 1.38
Idiopathic CD4+ T-lymphocytopenia--an analysis of five patients with unexplained opportunistic infections. N Engl J Med (1993) 1.38
Circulating hepatitis C virus genotypes in Spain. The Hepatitis/HIV Spanish Study Group. Vox Sang (1996) 1.38
[Serologic activity against retrovirus in patients with Sjögren syndrome]. Med Clin (Barc) (1993) 1.38
Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci U S A (1990) 1.36
Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.36
Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection. J Clin Microbiol (2000) 1.36
Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy. J Clin Microbiol (2000) 1.35
Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfection. AIDS Res Hum Retroviruses (2005) 1.34
Viral load differences in early infection with two HIV-1 subtypes. AIDS (2001) 1.34
Higher efavirenz plasma levels correlate with development of insomnia. J Acquir Immune Defic Syndr (2001) 1.33
Identification of single and dual infections with distinct subtypes of human immunodeficiency virus type 1 by using restriction fragment length polymorphism analysis. Virus Genes (1996) 1.33
Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1. J Infect Dis (2001) 1.33
Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load. J Med Virol (2000) 1.32
Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression. AIDS (1998) 1.31
Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV. BMJ (1990) 1.30
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA. HIV Med (2013) 1.28
Prevalence of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5. J Clin Microbiol (2001) 1.23
Diagnosis of visceral leishmaniasis in HIV-infected individuals using peripheral blood smears. AIDS (1993) 1.23
Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination. JAMA (1982) 1.22
Prevalence of mutations associated with reduced antiretroviral drug susceptibility among human immunodeficiency virus type 1 seroconverters in the United States, 1993-1998. J Infect Dis (2000) 1.20